EP3160489
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.6.2015EP published:
7.6.2023EP application number:
15732533.3
EPO information:
European Patent Register
Max expiry date:
25.6.2035
Title in English:
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITISLanguage of the patent:
English
Timeline
Today
26.6.2015EP application
7.6.2023EP Publication
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY
Inventor
Name:
COMBETTE, Jean-MarcAddress:
F-74140 Saint Cergues, FR
Name:
DELOCHE, CatherineAddress:
CH-1207 Genf, CH
Priority
Number:
PCT/EP2014/001736Date:
26.6.2014Country:
WO
Number:
PCT/EP2014/002724Date:
8.10.2014Country:
WO
Classification
Categories:
A61K 38/17, C07K 14/47, A61K 48/00, C07K 16/40, C12N 15/00, A61P 25/28, A61P 3/10, A61P 41/00, A61P 13/12, A61P 1/02, A61P 3/04, A61P 7/00, A61P 7/04, A61P 7/06, A61P 9/12, A61P 9/14, A61P 17/00, A61P 17/06, A61P 17/10, A61P 19/08